Assisted Reproductive Technology Market

Assisted Reproductive Technology Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The assisted reproductive technology market size is expected to reach US$ 66.74 Billion by 2032.

The assisted reproductive technology market is expected to grow at a CAGR of 10.3% from 2023 to 2032.

The assisted reproductive technology market size was estimated to be US$ 25.04 Billion in 2022.

Advancements in ART technologies and techniquesa and global prevalence of infertility has been increasing due to various factors are expected to drive Assisted Reproductive Technology (ART) market growth during the forecast period.

In-Vitro Fertilization (IVF) is the largest procedure type in the global Assisted Reproductive Technology (ART) market. The growing acceptance and adoption of IVF as a viable option for overcoming infertility have contributed to its dominant position in the ART market, making it the largest segment among the listed procedure types.

United States is the largest contributor to the North America assisted reproductive technology (ART) market.

Europe is prominent market for assisted reproductive technology. The region has a well-developed healthcare system, increasing prevalence of infertility, and supportive regulatory frameworks, which foster the growth of the ART market in Europe.

The procedure types of assisted reproductive technology include In-Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Transfer (FET), Donor Egg IVF, Surrogacy, others.

Cook Medical, CooperSurgical, Inc., Ferring Pharmaceuticals, Genea Limited, IGENOMIX, INVO Bioscience, IVFtech ApS, Merck KGaA, Nidacon International AB, OvaScience, Progyny, Inc., Vitrolife AB, Anecova, CryoChoice, ReproTech Ltd. among others, are the prominent players in this market.